Karen Knudsen: Collaboration as a Catalyst for Progress at Cancer 2035
Karen Knudsen/LinkedIn

Karen Knudsen: Collaboration as a Catalyst for Progress at Cancer 2035

Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:

“Excellent panel at Cancer 2035 focused on increasing public-private partnerships and collaborations that improve health. Perfect example from David Fredrickson on working together to increase lung cancer screening, amongst others. Inspiring group – let’s do more!”

Karen Knudsen

Other articles featuring Karen Knudsen on OncoDaily.